The Centers for Disease Control & Prevention (CDC) selected Sentry BioPharma Services, a provider of global biopharmaceutical cGMP warehouse, supply chain management, prescription drug distribution and clinical packaging services, to store and distribute influenza vaccine in support of its national strategic reserve.  

Sentry's extensive experience in cGMP warehousing and global distribution of vaccines will ensure product integrity, supply chain security and fast, efficient distribution of the vaccines. Sentry will warehouse and distribute up to 500,000 vaccine doses from its cGMP, US FDA registered facility.

"Sentry's vaccine storage and drug distribution services are specifically designed to support government entities, hospitals and public health care agencies," said Timothy Mitchell, Sentry's president. "Sentry has a history of supporting the CDC for vaccine distribution needs that require temperature maintenance, robust quality programmes and tailored distribution methodology.  Sentry will implement the 2012 contract for a third CDC success story since incorporating in 2005."

Sentry's vaccine storage and distribution service is designed to protect the efficacy of vaccine inventories throughout the supply chain. The company has the expertise, facility, personnel and protocols to securely store, accurately track and transport vaccines within the United States and beyond. Sentry's contracted services are ideally suited for both private and public entities that may require managing vaccine, pharmaceutical and biologic products.  Sentry's facility, systems and processes meet the CDC's recommendations for proper vaccine storage and handling procedures. Additionally, the company holds the appropriate local, state and federal licenses and accreditations for safely handling and transporting commercially approved drug products.

Sentry BioPharma Services maintains cGMP temperature-controlled storage for vaccine and other biopharmaceutical products, FDA labeling capability, drug distribution licenses and is located within a Foreign Trade Zone to exclusively serve the global pharmaceutical, biotechnology and health care industries.